Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales153 290177 526184 765189 168197 965207 857
EBITDA11 90813 053-12 50112 87513 451
Operating profit (EBIT)10 42711 3739 9879 90510 16310 575
Pre-Tax Profit (EBT)------
Net income5 2375 3176 6225 7686 1426 106
P/E ratio21,116,111,312,211,211,0
EPS ( $ )4,634,906,445,616,126,27
Dividend per Share ( $ )1,401,702,002,242,452,72
Yield1,43%2,15%2,76%3,26%3,56%3,95%
Reference price ( $ )97.7778.9172.568.7668.7668.76
Announcement Date02/09/2016
11:51am
02/09/2017
11:55am
02/08/2018
11:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt24 91724 07325 19520 75018 75811 018
Finance------
Operating income (EBITDA)11 90813 053-12 50112 87513 451
Leverage
(Debt/EBITDA)
2,09x1,84x-1,66x1,46x0,82x
Capital Expenditure2 3672 2241 9182 1522 1942 491
Book Value Per Share (BVPS)33,8 $34,7 $37,1 $40,4 $42,3 $45,2 $
Cash Flow per Share7,47 $9,33 $7,82 $8,68 $9,14 $9,90 $
Announcement Date02/09/2016
11:51am
02/09/2017
11:55am
02/08/2018
11:55am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 69 653 M$ -
Entreprise Value (EV) 90 403 M$ 88 411 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 12,2x 11,2x
Capitalization / Revenue 0,37x 0,35x
EV / Revenue 0,48x 0,45x
EV / EBITDA 7,23x 6,87x
Yield (DPS / Price) 3,26% 3,56%
Price to book (Price / BVPS) 1,70x 1,63x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 5,24% 5,13%
operating Leverage (Delta EBIT / Delta Sales) - 0,56x
Net Margin (Net Profit / Revenue) 3,05% 3,10%
ROA (Net Profit / Asset) 6,44% 7,08%
ROE (Net Profit / Equities) 15,4% 14,7%
Rate of Dividend 39,9% 40,0%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   1,14% 1,11%
Cash Flow / Sales 4,66% 4,68%
Capital Intensity (Assets / Sales) 0,47x 0,44x
Financial Leverage (Net Debt / EBITDA) 1,66x 1,46x
EPS & Dividend